Assessment of Feasibility and Outcomes of RUS Surgical Navigation System During Robot-Assisted Partial Nephrectomy for Small Renal Masses.
Sangmin Lee, Hyun Young Lee, Cheryn Song
https://pubmed.ncbi.nlm.nih.gov/39945060/Actively Recruiting
Led by Hutom Corp · Updated on 2025-09-11
204
Participants Needed
4
Research Sites
34 weeks
Total Duration
Researchers are evaluating the clinical effectiveness of the RUS NE Surgical Navigation System in patients undergoing robot-assisted partial nephrectomy for renal tumors. This randomized controlled trial aims to compare the operation time between patients using the RUS NE software and those who do not, with a goal to demonstrate a 10% reduction in surgery duration. The study involves 204 participants recruited from six medical centers in South Korea and focuses on assessing the feasibility and reliability of this imaging treatment planning software. Participants will be randomly assigned to one of two groups one group will have robot-assisted partial nephrectomy using the RUS NE software, which creates a 3D model of the tumor and surrounding organs based on CT images to assist surgical planning the other group will undergo the surgery without this software. The procedures will be performed following informed consent and randomization, and participants will be monitored during hospitalization and through outpatient follow-ups. During the study, researchers will collect data on operative time, tumor and vessel identification time, resection volume, and postoperative complications over a period of up to 16 weeks after surgery. Participants will undergo assessments during their hospital stay and outpatient visits for up to three months post-discharge, allowing evaluation of the softwares clinical impact and safety. The total study duration is 24 months starting from institutional review board approval.
CONDITIONS
A Multicenter Study of RUS NE
C
Cheryn Song, M.D.,Ph.D.
S
Suh Min Kim, M.D.,Ph.D.
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Hutom Corp
Lead Sponsor
Asan Medical Center
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Operative day plus hospitalization days
Participants undergo robot-assisted partial nephrectomy, either using the RUS NE surgical navigation system or without it. Clinical parameters related to the operation are evaluated during the hospitalization period.
1 hospital stay including surgery day and immediate post-operative care
Duration - Up to 3 months after discharge
Participants have outpatient follow-ups to monitor recovery, tumor and vessel status, resection volume, and any postoperative complications.
Multiple outpatient visits over approximately 3 months
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Sangmin Lee, Hyun Young Lee, Cheryn Song
https://pubmed.ncbi.nlm.nih.gov/39945060/Hutom Corp
Lead Sponsor
Asan Medical Center
Collaborating Sponsor